Singular Genomics Systems (OMIC) Short Interest Ratio & Short Volume $21.42 -0.48 (-2.19%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Singular Genomics Systems Short Interest DataSingular Genomics Systems (OMIC) has a short interest of 71,200 shares, representing 4.81% of the float (the number of shares available for trading by the public). This marks a -18.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 34,134 shares to cover all short positions.Current Short Interest71,200 sharesPrevious Short Interest87,800 sharesChange Vs. Previous Month-18.91%Dollar Volume Sold Short$948,384.00Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares2,510,000 sharesFloat Size1,480,000 sharesShort Percent of Float4.81%Today's Trading Volume10,608 sharesAverage Trading Volume34,134 sharesToday's Volume Vs. Average31% Short Selling Singular Genomics Systems? Sign up to receive the latest short interest report for Singular Genomics Systems and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMIC Short Interest Over TimeOMIC Days to Cover Over TimeOMIC Percentage of Float Shorted Over Time Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Singular Genomics Systems Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202471,200 shares $948,384.00 -18.9%4.8%0.7 $13.32 10/15/202487,800 shares $1.30 million -14.4%5.9%0.9 $14.84 9/30/2024102,600 shares $1.61 million -4.1%6.9%1.1 $15.67 9/15/2024107,000 shares $1.32 million +830.4%7.2%1.2 $12.38 8/31/202411,500 shares $81,738.55 -17.9%0.8%1.6 $7.11 8/15/202414,000 shares $100,604.00 -0.7%0.9%2.3 $7.19 Get the Latest News and Ratings for OMIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. 7/31/202414,100 shares $117,030.00 +13.7%1.0%2.4 $8.30 7/15/202412,400 shares $103,912.00 -17.9%0.9%2.2 $8.38 6/30/202415,100 shares $127,595.00 +109.7%1.1%2.6 $8.45 6/15/20247,200 shares $69,120.00 -97.0%0.0%1.5 $9.60 5/31/2024240,000 shares $87,528.00 -42.1%0.6%1.9 $0.36 5/15/2024414,400 shares $157,472.00 -37.9%1.0%3.3 $0.38 4/30/2024667,200 shares $267,547.20 +10.6%1.6%5.7 $0.40 4/15/2024603,300 shares $227,444.10 -17.6%1.4%5.3 $0.38 3/31/2024732,300 shares $376,548.66 -10.0%1.7%7.1 $0.51 3/15/2024813,500 shares $406,750.00 +7.3%1.9%6.5 $0.50 2/29/2024757,900 shares $432,003.00 -7.5%1.8%5.1 $0.57 2/15/2024819,000 shares $449,631.00 -5.9%2.0%4.9 $0.55 1/31/2024870,200 shares $439,451.00 -4.5%2.1%1.5 $0.51 1/15/2024911,200 shares $396,372.00 -17.2%2.2%1.6 $0.44 12/31/20231,100,000 shares $506,110.00 -5.2%2.6%1.9 $0.46 12/15/20231,160,000 shares $492,652.00 +3.6%2.8%2 $0.42 11/30/20231,120,000 shares $438,816.00 -27.3%2.7%1.9 $0.39 11/15/20231,540,000 shares $608,300.00 +40.0%3.7%2.6 $0.40 10/31/20231,100,000 shares $365,750.00 +8.9%2.7%2.3 $0.33 10/15/20231,010,000 shares $379,255.00 +3.4%2.5%4.2 $0.38 9/30/2023977,300 shares $372,351.30 +1.2%2.4%4.3 $0.38 9/15/2023965,800 shares $404,766.78 -3.3%2.4%3 $0.42 8/31/2023998,600 shares $469,242.14 +5.2%2.1%3.2 $0.47 8/15/2023949,400 shares $508,403.70 +1.7%2.0%3 $0.54 7/31/2023933,600 shares $740,251.44 +3.0%2.1%3.1 $0.79 7/15/2023906,200 shares $821,379.68 -0.1%2.0%3.2 $0.91 6/30/2023907,500 shares $753,225.00 -62.8%2.0%3.1 $0.83 6/15/20232,440,000 shares $2.08 million +10.9%5.5%8.3 $0.85 5/31/20232,200,000 shares $2.32 million +0.9%4.9%11.3 $1.06 5/15/20232,180,000 shares $1.95 million -0.9%4.9%12.1 $0.89 4/30/20232,200,000 shares $2.18 million +5.3%4.9%15 $0.99 4/15/20232,090,000 shares $2.15 million +3.0%4.7%14.8 $1.03 3/31/20232,030,000 shares $2.46 million +6.8%4.6%14.4 $1.21 3/15/20231,900,000 shares $2.43 million +8.6%4.3%14.1 $1.28917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today 2/28/20231,750,000 shares $3.76 million -0.6%3.9%14.3 $2.15 2/15/20231,760,000 shares $4.24 million -10.2%4.0%15.3 $2.41 1/31/20231,960,000 shares $5.24 million -15.2%4.4%15.5 $2.68 1/15/20232,310,000 shares $4.87 million -3.4%5.3%17.1 $2.11 12/30/20222,390,000 shares $4.80 million -8.4%5.5%17 $2.01 12/15/20222,610,000 shares $5.87 million +1.6%6.4%15.6 $2.25 11/30/20222,570,000 shares $5.24 million -6.6%6.3%12.2 $2.04 11/15/20222,750,000 shares $6.57 million -2.8%7.7%12.1 $2.39 10/31/20222,830,000 shares $7.53 million -9.6%7.9%10.3 $2.66 10/15/20223,130,000 shares $7.26 million -2.8%8.8%11.4 $2.32 9/30/20223,220,000 shares $8.05 million +1.9%9.0%11.9 $2.50 9/15/20223,160,000 shares $10.59 million -3.4%8.9%10.2 $3.35 8/31/20223,270,000 shares $8.73 million +5.1%9.2%11.3 $2.67 8/15/20223,110,000 shares $13.40 million +12.3%8.4%8.8 $4.31 7/31/20222,770,000 shares $10.55 million -8.6%8.0%7.8 $3.81 7/15/20223,030,000 shares $12.54 million +3.8%8.7%7.8 $4.14 6/30/20222,920,000 shares $11.15 million +16.8%9.0%6.9 $3.82 6/15/20222,500,000 shares $7.53 million +0.4%7.7%5.9 $3.01 5/31/20222,490,000 shares $8.09 million -10.1%7.7%4.8 $3.25 5/15/20222,770,000 shares $9.14 million +15.4%8.6%4.9 $3.30 4/30/20222,400,000 shares $9.82 million +9.6%8.1%4.4 $4.09 4/15/20222,190,000 shares $10.77 million -20.7%7.2%4.1 $4.92 3/31/20222,760,000 shares $17.42 million +43.8%9.0%5.2 $6.31 3/15/20221,920,000 shares $12.48 million +8.5%6.3%3.7 $6.50 2/28/20221,770,000 shares $14.57 million +4.1%5.7%4.3 $8.23 2/15/20221,700,000 shares $13.21 million +7.6%5.5%4.6 $7.77 1/31/20221,580,000 shares $12.25 million +46.3%4.4%4.8 $7.75 1/15/20221,080,000 shares $8.38 million -6.1%3.0%3.7 $7.76 12/31/20211,150,000 shares $13.29 million +13.9%3.2%4.4 $11.56 12/15/20211,010,000 shares $11.89 million -21.1%2.8%4.1 $11.77 11/30/20211,280,000 shares $14.62 million +14.3%3.7%6.1 $11.42 11/15/20211,120,000 shares $16.68 million +17.4%3.2%5.9 $14.89 10/29/2021954,300 shares $13.22 million -2.5%2.8%6.2 $13.85 10/15/2021978,500 shares $13.72 million +12.5%2.8%7.3 $14.02 9/30/2021869,600 shares $9.73 million +27.0%2.5%6.1 $11.19 9/15/2021684,900 shares $9.53 million +3.0%2.0%4.6 $13.92 8/31/2021665,300 shares $10.99 million +13.5%1.9%5 $16.52 8/13/2021586,000 shares $8.92 million No Change1.7%2.3 $15.23 OMIC Short Interest - Frequently Asked Questions What is Singular Genomics Systems' current short interest? Short interest is the volume of Singular Genomics Systems shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 71,200 shares of OMIC short. 4.81% of Singular Genomics Systems' shares are currently sold short. Learn More on Singular Genomics Systems' current short interest. What is a good short interest ratio for Singular Genomics Systems? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMIC shares currently have a short interest ratio of 1.0. Learn More on Singular Genomics Systems's short interest ratio. What is a good short interest percentage for Singular Genomics Systems? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.81% of Singular Genomics Systems' floating shares are currently sold short. Is Singular Genomics Systems' short interest increasing or decreasing? Singular Genomics Systems saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 71,200 shares, a decline of 18.9% from the previous total of 87,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Singular Genomics Systems' float size? Singular Genomics Systems currently has issued a total of 2,510,000 shares. Some of Singular Genomics Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Singular Genomics Systems currently has a public float of 1,480,000 shares. How does Singular Genomics Systems' short interest compare to its competitors? 4.81% of Singular Genomics Systems' shares are currently sold short. Here is how the short interest of companies compare to Singular Genomics Systems: Cara Therapeutics, Inc. (2.06%), Fulcrum Therapeutics, Inc. (9.21%), Quantum-Si incorporated (6.07%), Seer, Inc. (2.34%), Frequency Electronics, Inc. (0.29%), Kewaunee Scientific Co. (1.94%), Akoya Biosciences, Inc. (7.80%), 908 Devices Inc. (5.69%), Owlet, Inc. (3.70%), ClearSign Technologies Co. (0.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Singular Genomics Systems stock? Short selling OMIC is an investing strategy that aims to generate trading profit from Singular Genomics Systems as its price is falling. OMIC shares are trading down $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Singular Genomics Systems? A short squeeze for Singular Genomics Systems occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMIC, which in turn drives the price of the stock up even further. How often is Singular Genomics Systems' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMIC, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Cara Therapeutics Short Interest Data Fulcrum Therapeutics Short Interest Data Quantum-Si Short Interest Data Seer Short Interest Data Frequency Electronics Short Interest Data Kewaunee Scientific Short Interest Data Akoya Biosciences Short Interest Data 908 Devices Short Interest Data Owlet Short Interest Data ClearSign Technologies Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMIC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
